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SUMMARY 
Porphyromonas gingivalis and Tannerella forsythia secrete proteases, gingipains and KLIKK-
proteases. In addition, T. forsythia produces a serpin (miropin) with broad inhibitory 
spectrum. The aim of this pilot study was to determine the level of expression of miropin and 
individual proteases in vivo in periodontal and peri-implant health and disease conditions. 
Biofilm and gingival/peri-implant crevicular fluid (GCF or PISF respectively) samples from 
healthy tooth and implant sites (n=10), gingivitis and mucositis sites (n=12), and periodontitis 
and peri-implantitis sites (n=10). Concentration of interleukins (IL)-8, IL-1β and IL-10 in GCF 
was determined by ELISA. Loads of P. gingivalis and T. forsythia and the presence of 
proteases and miropin genes were assessed in biofilm by qPCR, while genes expression 
was estimated by qRT-PCR.   
Presence of P. gingivalis and T. forsythia, as well as the level of IL-8 and IL-1β, were 
associated with disease severity in the periodontal and peri-implant tissues. In biofilm 
samples harboring T. forsythia genes encoding proteases were found to be present at 72.4% 
for karilysin and 100% for other KLIKK-proteases genes and miropin. At the same time, 
detectable mRNA expression of individual genes was in the range from 20.7% to 58.6% 
samples (for forsylisin and miropsin-1, respectively). In comparison to the T. forsythia 
proteases, miropin and the gingipains were highly expressed. The level of expression of 
gingipains was associated with those of miropin and certain T. forsythia proteases around 
teeth but not implants. Cumulatively, KLIKK-proteases and especially miropin might play a 
role in pathogenesis of both periodontal and peri-implant diseases.     
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INTRODUCTION 
According to an emerging paradigm, pathogenesis of periodontal disease is considered as a 
result of disturbed homeostasis within tooth-supporting tissues by dysbiotic microbiota 
leading to inflammation and slowly eroding periodontal tissues.1 Using murine model of 
diseases it was shown that the presence of certain bacteria might influence the entire 
microbiome around the tooth by modulating the immune response, thus leading to a shift 
from a symbiotic into a dysbiotic microbiota.1 In particular, P. gingivalis was designated as a 
keystone pathogen in this transition.2 The virulence of P. gingivalis heavily relies on its 
arginine- and lysine-specific cysteine proteases, called gingipains.3, 4 The arginine-specific 
gingipains (RgpA and RgpB) are encoded by two genes, rgpA and rgpB. The lysine-specific 
gingipain (Kgp) originates from a single gene, kgp.5 Gingipains can skew the immune 
response by cleaving immunoglobulin G1, interfering with the complement system, and 
disassembling cytokine cross-talk networks.6, 7 
Apart from P. gingivalis other bacterial species such as T. forsythia may play a similar key 
role. T. forsythia, together with P. gingivalis, is a part of the so called red complex,8 and they 
are very often found together in sites with periodontal destruction.9, 10 For example, T. 
forsythia was detected in approximately 50% of young adult patients with gingivitis,11 while in 
85% of cases in subjects with chronic periodontitis often (50% cases) in association with P. 
gingivalis.10 However, little is still known regarding the virulence factors of T. forsythia. The 
genome of T. forsythia contains many sequences that apparently encode proteases.12 In 
particular, 6 enzymes with a KLIKK sequential motive at the C-terminus and therefore 
referred to as KLIKK-proteases are of interest as putative virulence factors.12 Interestingly, T. 
forsythia also secretes miropin, a potent protease inhibitor belonging to the serpin 
superfamily, which may contribute to pathogenicity. The unique feature of miropin is the 
ability to inhibit a broad range of target proteases, including neutrophil-derived cathepsin G 
and elastase important for antibacterial activity of these phagocytes.13, 14  
During the last 2-3 decades, replacement of teeth with implants became a predictable and 
widely used therapy. However, peri-implant diseases are now becoming increasingly 
prevalent and negatively impacting oral health. In a recent systematic review, the weighted 
mean prevalence of peri-implant mucositis and peri-implantitis among individuals with 
implants was 43% and 22%, respectively.15 Despite major similarities in the pathogenesis of 
peri-implant diseases with that of periodontal diseases, there are apparent differences in the 
host response to the bacterial challenge in these diseases.16 For example, T. forsythia 
appears to play a greater role in pathogenesis of peri-implant disease than in periodontitis. 
Ten years after placement of implants, greater numbers of T. forsythia were found at implant 
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sites than at the adjacent teeth in correlation with disease severity.17 The tissue destruction 
in peri-implantitis seems to be more progressive and extensive than in periodontitis.18 So far, 
however, it is not known which T. forsythia putative virulence factors are expressed in vivo 
and whether there are differences in their expression between periodontal and peri-implant 
diseases and/or disease severity. 
Thus, the aim of this pilot study was to investigate expression of T. forsythia miropin and 
KLIKK-proteases in vivo in periodontal and peri-implant diseases, correlate differences in 
their expression with the disease entity, and determine a possible association between 
expression of T. forsythia and P. gingivalis proteases in sites infected with both pathogens.   
 
MATERIALS AND METHODS 
Subject recruitment 
Thirty-two subjects were recruited from patients attending the specialty clinic at the 
Department of Periodontology, Faculty of Odontology, Malmö University, Malmö, Sweden. 
These subjects contributed with periodontally healthy sites and healthy implants (n=10), with 
gingivitis and mucositis sites (n=12), as well as with periodontitis and peri-implantitis sites 
(n=10). 
Periodontal diseases (gingivitis, periodontitis) were defined based on the classification 
system established in 1999,19 while peri-implant diseases (mucositis and peri-implantitis) 
were defined according to Zitzmann and Berglundh.20 An ethical approval was granted by the 
Regional Ethics Committee in Lund, Sweden (Dr. nr.; 2014/700), and all patients signed an 
informed written consent prior to entering the study. 
 
Sampling 
Samples were obtained from the site of the tooth or implant with the deepest pocket depth, 
according to existing dental record registrations, using paper points and paper strips. The 
periodontal or peri-implant probing depths were < 4 mm in periodontal health, 3 – 5 mm in 
gingivitis, 3-6 mm in peri-implant-health or mucositis, 5 - 9 mm in case of periodontitis and 6 
– 9 mm in peri-implantitis lesions. For collecting gingival crevicular fluid (GCF) or peri-implant 
sulcular fluid (PISF) the site was gently air dried and isolated by cotton rolls; then paper 
strips were inserted in the entrance of the sulcus (superficial method)21 for 30 s. This 
procedure was immediately followed by collection of subgingival biofilm. For this, endodontic 
paper points were inserted into pockets until resistance from the base of the pocket was felt 
and were kept in place for 30 s. After sampling, paper strips and points were stored in sterile 
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tubes. The tubes for storing paper points also contained 300 μl of RNAlater (RNAlater®, 
Sigma-Aldrich, St. Louis, USA). Paper points and strips were stored shortly after collection at 
-80°C until processed. 
 
Levels of GCF/PISF biomarkers 
GCF/PISF samples were eluted in 750 µl phosphate-buffered saline (PBS) overnight at 4°C. 
The levels of interleukin (IL)-8, IL-1β and IL-10 in the GCF/PISF were determined by using 
commercially available ELISA kits (DuoSet® ELISA Development Systems kits (R&D 
Systems, Inc., Minneapolis, Minnesota, USA) according to the manufacturer’s instructions. 
The detection levels were 1 pg/site each.   
 
DNA/RNA extraction 
DNA and RNA were extracted simultaneously from paper points using a DNA/RNA extraction 
kit (innuPREP DNA/RNA Mini Kit, Analytik Jena, Jena, Germany) according to the 
manufacturer’s instructions. 
 
Determination of bacterial counts 
To determine counts of bacteria being associated with periodontitis (P. gingivalis, T. 
forsythia, Treponema denticola, Aggregatibacter actinomycetemcomitans), the real-time 
polymerase chain reaction (PCR) was performed using the 7500 Real-time PCR System 
(Applied Biosystems™, Foster City, USA) and reference strains as described previously.22 
The detection level was determined as 103 bacteria per sample.  
 
Expression of bacterial proteases and miropin 
To determine the in vivo expression of T. forsythia proteases miropsin-1, miropsin-2, 
mirolysin, mirolase, karilysin and forsylisin-1, the protease inhibitor miropin, and the 
gingipains rgpA, rgpB and kgp, cDNA was amplified from total RNA obtained from the paper 
points. The RNA was first treated with DNase I, RNase-free (ThermoFisher Scientific, 
Waltham, Massachusetts, USA) and thereafter cDNA was generated using RevertAid 
Reverse Transcriptase (ThermoFisher Scientific) according to the manufacturer’s 
instructions.  
Real-time PCR using GoTaq® qPCR Master Mix (Promega) and the respective primers 
(Table 1) was performed for different bacterial proteases and miropin according to the 
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manufacturer’s instructions. Quantification was made related to the sod gene expression of 
respective bacteria.  
Negative controls contained 1:5 diluted RNA (before generation of cDNA) and as positive 
controls cDNA generated from RNA of 24 h-cultures of P. gingivalis ATCC 33277 as well as 
of T. forsythia ATCC 43037 were used.  
 
Statistics 
Statistical analysis was performed using non-parametric tests (Kruskal-Wallis, Mann-
Whitney, Friedman tests) for continuous variables and Chi2-test for dichotomized variables, 
with SPSS 23.0 (IBM, Chicago, IL, USA). 
 
RESULTS 
 
Presence of bacteria and biomarkers levels in gingival / peri-implant fluid 
There were no statistically significant differences between biofilms collected from the teeth 
and implants in terms of frequency of detection and numbers of the various bacteria at health 
and at the various disease severities. In both cases bacterial presence increased from health 
to disease in correlation with severity of periodontal and peri-implant destruction (Table 2). 
The differences between healthy and diseased sites were statistically significant for T. 
forsythia and T. denticola, both, at the teeth (p=0.024; p=0.007) and at implants (p=0.011; 
p=0.004).  
In GCF collected from periodontal sulci or pockets around teeth, the level of IL-8 correlated 
with the severity of periodontal disease (p=0.048), and it was significantly higher in 
periodontitis than in gingivitis (p=0.036) or in health (p=0.029). Amount of IL-1β in GCF also 
varied in a manner dependent on the periodontal disease severity (p=0.010). At teeth, levels 
of IL-1β were higher in periodontitis than in gingivitis (p=0.004), whereas at implants there 
was no statistically significant difference between mucositis and peri-implantitis but only 
between the health and mucosistis sites (p=0.025) and between the health and peri-
implantitis sites (p=0.043). Comparing teeth with implants, the levels of IL-1β in periodontitis 
exceeded those in peri-implantitis (p=0.035). The anti-inflammatory IL-10 was lower in 
periodontitis and peri-implantitis in comparison with gingivitis (p=0.021) and mucositis 
(p<0.001). Results with statistically significant differences are presented in Figure 1.     
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Porphyromonas gingivalis and expression of gingipains 
Expression of gingipains genes was standardized on expression of the housekeeping gene 
sod.  In samples with P. gingivalis counts less than 105 we sometime failed to detect the sod 
transcript therefore we have compared gingipain expression levels only in samples with ≥105 
bacteria per site. In this subset of samples expression of each gingipain was always 
detectable, with kgp expression being the highest, followed by rgpA and rgpB (p<0.001) 
(Table 3).  
 
Tannerella forsythia and expression of its proteases and miropin 
The part of samples bearing less than 105 T. forsythia were excluded from quantitative 
analysis because no mRNA for the sod gene could be detected (Table 4). In the subset of 
biofilm samples with bacterial load >105 the detection of the protease genes varied from 
72.4% (karilysin) to 100% (miropsin-2, mirolysin, mirolase, miropin) of the samples. 
Detectable amount of mRNA of protease genes transcripts was found at lower frequency 
ranging from 20.7% (forsylisin-1) to 58.6% (miropsin-1) of the samples. Quantitatively except 
for one peri-implantitis specimen having high level of miropsin-2, in all other samples 
expression of any protease gene was always low (in comparison to sod).  
In T. forsythia-positive samples (bacterial count over 105) there was no statistically significant 
difference in detection of protease gene transcripts in samples collected from the tooth and 
implant sites (Table 5). Exception was miropsin-2 showing higher levels of expression in 
periodontitis or peri-implantitis than in periodontal health/gingivitis or peri-implant 
health/mucositis (teeth: p=0.015; implants: p=0.044).  
Contrary to the proteases, miropin was highly expressed. In all samples positive for T. 
forsythia, miropin was detected on the mRNA level. In samples with ≥105 T. forsythia 
expression was in median 2.34 related to sod (Table 4). 
 
Correlation of proteases expressions 
Expression of the three gingipains was highly correlated, both at teeth (r=0.890 up to 
r=0.972, each p<0.001) and implants biofilms (r=0.996 up to r=0.999, each p<0.001). Also 
expression of T. forsythia proteases was correlated, with the strongest correlation seen for 
karilysin and forsylisin-1 (r=0.856, p<0.001), then miropsin-1 and mirolase (r=0.769, p<0.001) 
in biofilm derived for the subgingival teeth surface. In biofilm collected from the implant sites 
the strongest correlation was found between mirolase and miropsin-2 (r=0.796, p<0.001) and 
then between mirolase and miropsin-1 (r=0.790, p<0.001). In biofilm collected from teeth also 
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the miropin expression was found to correlate with those of miropsin-1 (r=0.740, p<0001) 
and miropsin-2 (r=0.784, p<0.001). In case of the biofilm from implants the correlation factor r 
did not exceed 0.6 for any combination of T. forsythia protease genes expression.   
In biofilm collected from tooth sites, gingipains mRNA levels correlated with expression of the 
T. forsythia proteases. The strongest correlation was found between rgpB or kgp with 
miropsin-2 (r=0.523, p=0.002; r=503, p=0.003, respectively) and between kgp and mirolase 
(r=0.501, p=0.003). There was also a positive correlation between gingipains and miropin 
expressions (rgpA: r=0.536, p=0.002; rgpB: r=0.429, p=0.014, kgp: r=0.550, p=0.001).   
In biofilm from implant sites, no significant correlation between gingipains and any of T. 
forsythia proteases was detected (r was always below 0.5). The same was observed for 
relation between the miropin and gingipain expression.  
In samples collected from teeth sites, gingipain expression in biofilm did not correlate with 
the levels of biomarkers in GCF. In contrast, the expression of certain T. forsythia proteases 
correlated positively with the IL-1β GCF level. This was found for miropsin-1 (r=0.417; 
p=0.018) and karilysin (r=0.406, p=0.021). In samples from implant sites, expression of 
miropsin-1 was positively associated with levels of IL-1β (r=0.417, p=0.018) and negatively 
associated with those of IL-10 (r=-0.430, p=0.014). Also the expression of miropsin-2 (r=-
0.391, p=0.027) and mirolase (r=-0.510, p=0.003) were inversely correlated with IL-10 levels 
in PISF. No association of the miropin expression with the biomarker levels was observed.  
Found correlations were underlined by a principal components analysis, where components 
with more than 20% variance were considered (Table 6). Principal components analysis is a 
multivariate statistical method used to find hidden complex, and possible relationships 
between features in a data set. Correlated features are converted by means of the principal 
axes transformation into new features, the so-called ‘principal components’ where the 
importance of a factor (variable) is expressed by its loading.  The principal components 
themselves are uncorrelated.23  
The clear association between certain T. forsythia proteases is visible both in the teeth- and 
implants-derived biofilms. In this analysis, miropin has only a relevant loading at teeth, and 
biomarkers (IL-8, IL-1β) are linked with karilysin expression also in the teeth-surface biofilm.   
 
DISCUSSION 
In this study, the presence and expression of P. gingivalis and T. forsythia proteases and the 
bacterial protease inhibitor, miropin, was assessed in biofilm samples derived from teeth and 
implants, in health and disease. Of note, instead the 16S RNA gene known to differ in 
number of copies even within one species24 we chose sod as a reference gene. Being aware 
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that sod expression depends on oxygen tension25 we assumed that sampled sites were 
rather uniform with respect to anaerobic conditions and small variations in oxygen tension 
should not significantly affect local sod expression. The above threshold level of mRNA of 
bacterial sod was reliably and quantitatively measured in all samples having a bacterial load 
equal or higher than 105 bacteria per site. Groups were differentiated related to the degree of 
inflammation without alveolar bone loss and showing different levels of pathological bone 
destruction. Both pro-inflammatory biomarkers, IL-8 and IL-1β increased from health to 
disease, and with disease severity, i.e. from gingivitis/mucositis to periodontitis/peri-
implantitis.  On the other hand, the level of the anti-inflammatory IL-10 was high at inflamed 
sites and low at sites exhibiting bone destruction, both at implants and at the teeth. The 
finding of higher levels of IL-1β and lower levels of IL-10 at peri-implantitis sites is in 
accordance with the observation by Casado et al.26 Interestingly, in contradiction to the 
observation by Hultin et al.27 showing similar levels of this cytokine in sites with peri-
implantitis and periodontitis collected from the same patient, we have found lower levels of 
IL-1β at peri-implantitis sites than in GCF collected from periodontitis sites. This discrepancy 
suggests that more detailed studies need to be performed to differentiate importance of 
cytokines in the pathology of peri-implantitis and periodontitis.  
 
As expected, disease severity was associated with an increased prevalence of certain 
bacterial species, i.e. a significantly larger numbers of T. forsythia and T. denticola were 
found at periodontitis/peri-implantitis sites compared to gingivitis/mucositis sites, and in 
gingivitis/mucositis sites they were more abundant than in healthy sites. However, there was 
never a difference between the bacterial counts at the teeth and implants, collected from 
sites of the comparable severity, i.e. gingivitis versus peri-implant mucositis, and periodontitis 
versus peri-implantitis. In general, our finding of correlation between the pathogens load and 
the disease severity is in accordance with results reported by Cortelli et al. 28 In this study 
authors counted periodontal pathogens collected from around teeth and implants from two 
independent groups of individuals. They found lower amount of T. denticola and T. forsythia 
at implants in comparison with the teeth.28  This observation contradicts our finding but the 
discrepancy must be due to different experimental set-up. On the other hand, the fact that T. 
denticola and T. forsythia can easily transmit from a periodontally diseased tooth to an 
implant29-31 and probably vice versa, explains the comparable load of these periodontal 
pathogens around the diseased teeth and implants herein.  
P. gingivalis cysteine proteases (gingipains) were always expressed both at implants and at  
teeth, which corroborates with results of our recent in vitro study using titanium and dentine 
disks.32 The highest mRNA expression related to sod was found for kgp, followed by rgpA 
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and rgpB. Level of Kgp was determined as being up to 10 nM in periodontium,33 those of 
Arg-gingipains up to 1.5 µM.34 Unfortunately, there is still a little data on gingipains level at 
peri-implantitis sites. DNA of rgpA, rgpB and kgp was used as vaccines in an animal model 
with kgp being most efficiently blocking bone loss in experimental peri-implantitis whereas 
rgpB was ineffective.35 Gingpains are able to cleave adherence junctions of epithelial cells,36 
a property which may impair epithelial barrier around implants. Moreover, gingipain-
dependent manipulations of recruitment and functions of neutrophils,37 exploitation of the 
complement system, activation of the kinin system leading to activation of prostaglandin in 
osteoblasts and extravasation,6 might be of importance both at the teeth and implants.      
Expression of T. forsythia proteases was found at lower level than that of gingipains. 
Protease genes transcripts were determined in 20 – 59% of the samples with T. forsythia 
load exceeding ≥105 bacterial cells.  This result confirms findings of our recent study on 
patients with periodontitis, in which the in vivo expression of karilysin and mirolysin was 
experimentally verified in a small set of samples.38, 39 In the present study, mainly transcripts 
(mRNA) of miropsin-1, miropsin-2 and mirolase were found. In general, expression of T. 
forsythia proteases, in particular miropsin-2 was associated with periodontal or peri-implant 
destruction supporting a potential role of the KLIKK-proteases in disease progression. There 
is little known about miropsin-1 and miropsin-2 up to now. Miropsin-1 and miropsin-2 are 
proteolytically active when using casein or gelatine as substrates, however their activity was 
lower when compared to other KLIKK proteases.40 Nevertheless, they may specifically target 
molecules important for local homeostasis in periodontal tissues.  In contrast to other KLIKK 
proteases, miropsin-2 is not auto-processing into lower molecular mass forms.40 Finally, 
mirolase was characterized as a calcium-dependent serine protease with the ability to 
degrade fibrinogen and hemoglobin.12   
Karilysin and mirolysin expression was found in about 40% of the samples with more than 
105 T. forsythia. Karilysin was characterized as a matrix metalloprotease-like enzyme able to 
degrade elastin, fibrinogen and fibronectin.41 The pathogenic potential of karylisin  to  
interfere with innate immunity is manifested by its ability to inactivate the antimicrobial 
peptide LL-3742 and to induce expression of TNFα in macrophages, and then shedding it 
from the macrophage surface thus leading to an increased release of this proinflammatory 
cytokine.43 Similar to karilysin, the metalloprotease mirolysin can also inactivate LL-37.44 
Both karilysin and mirolysin inhibit all pathways of the complement system.38, 39 Expression of 
T. forsythia proteases was highly correlated at the teeth and furthermore associated also with 
gingipains expression. Synergism between gingipains and T. forsythia has been investigated. 
Gingipains are involved in a synergistic increase of IL-6 production of macrophage-like cells 
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when infected with T. forsythia and P. gingivalis.45  Gingipains enhance phagocytosis of T. 
forsythia, but diminish their killing by macrophages.46 Further research should focus on the 
potentially synergistic role of KLIKK proteases and gingipains in pathogenesis of periodontal 
and peri-implantitis diseases.  
Miropin, a protease inhibitor belonging to the serpin superfamily was highly expressed. The 
miropin mRNA level in tested samples was higher than that of sod, the house-keeping gene 
used as the reference. Bacterial serpins are mainly found in commensals. Eubacterium 
sireaum, an inhabitant of the human gut, synthesizes serpins which inhibit neutrophil 
elastase, protease 3 and certain gut proteases and in this way may contribute to 
homoeostasis in the gut.47 Also miropin is the very potent inhibitor of serine endopeptidases, 
such as cathepsin G and neutrophil elastase.13 T. forsythia obviously acquired this serpin 
gene by horizontal gene transfer from eukaryotes.14 Miropin is attached to the bacterial cell 
surface and also located in the periplasm exerting protection against T. forsythia own 
proteases as well as host and other bacteria enzymes, which may degrade the surface S-
leyer.13 At the teeth, expression of miropin was not only strongly associated with the T. 
forsythia proteases, but also correlated with gingipains. This suggests that gingipains might 
be involved in regulation of miropin or vice versa. It can be speculated that the pathogenetic 
role of miropin is exerted by maintenance of inflammation at a low chronic level.   
Correlation assessment made separately or by the principal components analysis showed 
differences between the teeth and implants. It is of interest to note, that significant 
associations between biomarkers’ levels, and expression of gingipains and T. forsythia 
proteases and miropin was found only at teeth. Specifically, expression of the KLIKK 
proteases, as well as the protease inhibitor miropin by T. forsythia was correlated with 
gingipains. Furthermore, karilysin positively correlated with pro-inflammatory biomarkers and 
negatively with the anti-inflammatory cytokine IL-10. At implants there was no significant 
association between miropin and gingpains or between miropin and the T. forsythia 
proteases. Also no correlation was found between bacterial proteins and the analyzed 
biomarkers. This may suggest a substantial difference in regulation of bacterial virulence 
factor expression and host responses to bacteria at implants and teeth, which may partly be 
due to the existing anatomical differences between implants and teeth. For example, 
Sharpey’s fibres form a complex network around the teeth together with a vascular plexus, 
whereas dental implants are surrounded by collagen fibres run in parallel and there are a few 
blood vessels48 thus the established peri-implant soft tissue resembles a scar tissue.49 
Further, it has been shown that implant sites respond with a stronger inflammatory reaction 
than teeth sites when exposed to biofilm.50 Another factor contributing to differences may be 
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related to variations in biofilm formation on the tooth and implant surface. Recently an in vitro 
study found that miropin expression was lower at titanium implants  than at dentine disks.32 
However, the miropin expression by T. forsythia adhered either to the dentin or titanium 
surface exceeded up to 500-fold the expression of proteases (miropsin-1, miropsin-2, 
mirolase.32  It is clear that more research is needed on T. forsythia, not only as the 
periodontal pathogen, but also a potentially pathogenic member of the peri-implant biofilm 
consortium.        
In summary, the focus of this study was on in vivo expression (mRNA levels) of the 
proteases and the protease inhibitor by periodontal pathogens. Our results showed much 
higher expression of gingipains of P. gingivalis and miropin of T. forsythia than the KLIKK 
proteases of the latter bacterium.  Taking into account a broad inhibitory spectrum of miropin, 
this data suggest that this protein may play a regulatory role in a multispecies dysbiotic 
biofilm forming on teeth and implant surfaces and may contribute to the initiation and/or 
progression of both periodontal and peri-implant diseases.     
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Table 1 
Primer pairs used in real-time PCR for detection of bacterial proteases (rgpA, rgpB, kgp, miropsin-1, miropsin-2, mirolase) and of T. forsythia 
protease inhibitor (miropin) as well as the house keeping genes (sod)  
 
Species Gene Primer Reference 
P. gingivalis rgpA fwd: 5′-TAT CCT TCG TGA TGT GCG TG-3′  
rev: 5′-GCT GTA ACG GGA GAA GCA AT-3′  
Frohlich et al. 51 
 rgpB fwd: 5′-CAT TCT CCT CTC TGT TGG GA-3′ rev: 5′-
CGT AGG GGA TTT GAT CAG GA-3′  
Frohlich et al.51 
 kgp fwd: 5′-TCA AGC AGT TCG ATG CAA GC -3′  
rev: 5′-ACT TGG GTC AGT TCT TGT CC-3′  
Frohlich et al.51 
 sod fwd: 5′-AAT TCC ACC ACG GTA AGC AC-3′ 
5′- TTC TCG ATG GAC AGT TTG CC-3′ 
Frohlich et al.51 
T. forsythia miropsin-1 fwd: 5’-CGT GCG TGA AGA AGC CAT TA-3′ 
rev: 5’-AAC CCG GAT GTT CAT ACC CC-3′ 
according to Ksiazek et al.40  
 miropsin-2 fwd: 5’-TCC TGA CCG ACC TGA TCA AA-3’ 
rev: 5’-TCG GCA TTG GAA ATT TCG GA-3′ 
according to Ksiazek et al.40 
 karilysin fwd: 5’- TTA CAG TTG CGG CAC ATG AG-3’ 
rev: 5’- TGT TAA TGG TTG CTC GCA CT -3′ 
accession: Tf 0367; BFO2683 
 mirolysin fwd: 5’- CGA ACA TCG ACT TCC ACA GA-3’ 
rev: 5’- TGT TTT AGG GAA CGA AGG ACA -3′ 
accession: Tf0341; BFO2661 
 mirolase fwd: 5’-TGC CGC AAA TCA TAA TGG TA 
rev: 5’-GTC CAT CCC TTC CTT GAG TG-3′ 
according to Ksiazek et al.40 
17 
 
 forsylisin-1 fwd: 5’- GAT GAT GGG TTT ACA ATT GAC G-3’ 
rev: 5’- TCT AGT AAT TTG TTC TCC AAT TTG C -3′ 
accession:Tf2162; BFO1168 
 miropin fwd: 5‘-ATG CCT TTG CCT TCG ATC TG-3′ 
rev: 5‘-CTT CCC GTA GTG AAT GGC TG-3′ 
according to Ksiazek et al.13 
 sod fwd: 5’-GCA CGT CTG TTC TGG TAA TCC-3′ 
rev: 5’-CCT GCA ATT CAA GCC TCA GA-3′ 
accession: JUET01000058.1 
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Table 2 
Presence of selected species in subgingival and peri-implant biofilm 
 
Species Healthy gingivitis / mucositis periodontitis / peri-implantitis 
tooth (n=10) implant (n=10)  tooth (n=12) implant (n=12)  tooth (n=10) implant (n=10)  
A. actinomycetemcomitans 1 (10.0) 2 (20.0) 3 (25.0) 3 (25.0) 3 (30.0)   3 (30.0) 
P. gingivalis 3 (30.0) 2 (20.0) 4 (33.4) 2 (16.7) 5 (50.0)   6 (60.0) 
T. forsythia 2 (20.0) 4 (40.0) 5 (41.7) 6 (50.0) 8 (80.0) 10 (100) 
T. denticola 1 (10.0) 3 (30.0) 5 (41.7) 6 (50.0) 8 (80.0) 10 (100) 
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Table 3 
DNA (dichotomized results) and mRNA expression of gingipains in samples with less (dichotomized results) and equal or more than 105 
(dichotomized results and quantitative data related to sod) Porphyromonas gingivalis 
 positive <100,000 (n=11) positive ≥100,000 (n=11) 
DNA  
n (%) 
mRNA  
n (%) 
DNA  
n (%) 
mRNA  
n (%) 
related to sod 
median             minimum           maximum 
rgpA   4 (36.4) 1 (9.1) 11 (100) 11 (100)   0.246 <0.001  24.859 
rgpB   6 (54.6) 1 (9.1) 11 (100) 11 (100)   0.011 <0.001  15.122 
kgp   8 (72.7) 2 (18.2) 11 (100) 11 (100) 27.611 <0.001 566.65 
sod 10 (90.9) 7 (63.6) 11 (100) 11 (100)    1   1    1 
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Table 4 
DNA (dichotomized results) and mRNA expression of Tannerella forsythia proteases and miropin in samples with less (dichotomized results) and 
equal or more than (dichotomized results and quantitative data related to sod) 105 T. forsythia 
 
 positive <100,000 (n=6) positive ≥100,000 (n=29) 
DNA  
n (%) 
mRNA  
n (%) 
DNA  
n (%) 
mRNA  
n (%) 
related to sod 
median              minimum          maximum 
miropsin-1 5 (83.3) 1 (16.7) 27 (93.1) 17 (58.6) <0.001  0.000  0.615 
miropsin-2 3 (50.0) 0 (0) 29 (100) 14 (48.3)  0.001  0.000  3.051 
karilysin 4 (66.7) 1 (16.7) 21 (72.4) 11 (37.9)  0.000  0.000  0.792 
mirolysin 4 (66.7) 0 (0) 29 (100) 11 (37.9)  0.000  0.000  0.008 
mirolase 4 (66.7) 0 (0) 29 (100) 15 (51.7)  0.006  0.000  0.380 
forsylisin-1 0 (0) 0 (0) 25 (86.2)   6 (20.7)  0.000  0.000  0.012 
miropin 6 (100) 6 (100) 29 (100) 29 (100)  2.340 <0.001 17.609 
sod 6 (100) 3 (50) 29 (100) 29 (100)  1  1  1 
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Table 5 
mRNA expression (dichotomized results) of Tannerella forsythia proteases and miropin related to clinical data    
 Tooth implant 
healthy   
n (%) 
gingivitis  
n (%) 
periodontitis  
n (%) 
healthy   
n (%) 
mucositis  
n (%) 
peri-implantitis  
n (%) 
Total  2 4 8 2 4 9 
miropsin-1 1 (50.0) 2 (50.0) 7 (87.5) 0 (0) 2 (50.0) 5 (55.6) 
miropsin-2 0 (0) 2 (50.0) 7 (87.5) 0 (0) 0 (0) 5 (55.6) 
karilysin 0 (0) 0 (0) 5 (62.5) 0 (0) 2 (50.0) 5 (55.6) 
mirolysin 1 (50.0) 1 (25.0) 3 (37.5) 0 (0) 1 (25.0) 5 (55.6) 
mirolase 0 (0) 2 (50.0) 6 (75.0) 0 (0) 1 (25.0) 6 (66.7) 
forsylisin-1 0 (0) 0 (0) 3 (37.5) 0 (0) 1 (25.0) 2 (22.2) 
miropin 2 (100) 4 (100) 8 (100) 2 (100) 4 (100) 9 (100) 
  
(only samples with T. forsythia ≥105) 
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Table 6  
Principal components analysis (loadings of the main components) at teeth and implants  
 
Variable Principal component teeth 
Component 1            Component 2 
Principal component implants 
Component 1            Component 2             
rgpA 0.616 0 0 0.939 
rgpB 0 0 0 0.937 
kgp 0 0 0 0.885 
miropsin-1 0.743 0 0 0 
miropsin-2 0 0 0.873 0 
karilysin 0 0.645 0 0 
mirolysin 0 0 0.708 0 
mirolase 0.906 0 0.910 0 
forsylisin-1 0.877 0 0.855 0 
miropin 0.741 0 0 0 
IL-8 0 0.549 0 0 
IL-1β 0 0.867 0 0 
IL-10 0 -0.600 0 0 
% of variance 25.23 21.00 25.57 23.09 
Components with a variance ≥ 20% are presented. Loadings of the principal components < |0.5| are set to 0 for greater clarity. 
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Figure 1 
Levels of the chemokine interleukin (IL)-8 (i), and of the cytokines IL-1β (ii) and IL-10 (iii) at 
teeth being periodontally healthy (healthy), with gingivitis (gin) and with periodontitis (perio) 
sites as well as at implants being healthy, with mucositis (muc) and with peri-implantitis (peri-
impl)  
Statistical analysis compared cytokines levels at teeth and at implants as well as between 
the healthy sites and sites with inflammation (gingivitis, mucositis) and between sites with 
alveolar bone loss (periodontitis, peri-implantitis).    
 
